天天彩票投注


  • Company Profile
  • History

Genzon Pharmaceutical Group

Committed to be the benchmarking biotech company in China

 

Genzon pharmaceutical Group is a wholly owned modern Pharmaceutical enterprise which was funded and operated by Genzon Group. It integrates the R&D, producing and selling of pharmaceutical products. Genzon Phamaceuticals Group owns four subsidiaries: Shenzhen Kexing Biotech Co., Ltd., Shandong Kexing Bioproducts Co., Ltd, Shenzhen Tongan pharmaceuticals Co., Ltd. and Shenzhen Kexing pharmaceuticals Import & Export Co., Ltd.

 

With years of efforts, Genzon Pharmaceuticals Group has achieved its strong strength and competitive advantage in the industry. Currently, the Group’s main products include Recombinant Human Interferon α 1b for Injection(SINOGEN), Recombinant human Erythropoietin(EPOSINO), Recombinant Human Granulocyte Colony-Stimulating Factor Injection (WHITE-C), Clostridium butyricum Bifidobacterium (CHANGLEKANG), Chinese traditional patent pharmaceutical Kehuang Capsule, etc.

 

Moving forward, Genzon pharmaceutical Group will make a good use of its new platform, to develop a multi-product combination with Chemical drugs, traditional Chinese medicines, and health care products. The company wishes to contribute to the pharmaceutical industry and human health improvement by focusing on "Liver disease, kidney disease, cancer, and pediatrics"areas.  

History

  • 1989
  • 1993
  • 1995
  • 1996
  • 1997
  • 1998
  • 1999
  • 2001
  • 2002
  • 2003
  • 2008
  • 2016

Products & Service

Continue to understand >